Delcath Operating Margin from 2010 to 2024
| DCTH Stock | USD 12.64 0.76 6.40% |
Check Delcath Systems financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Delcath Systems' main balance sheet or income statement drivers, such as Depreciation And Amortization of 121.6 K, Interest Expense of 2.3 M or Selling General Administrative of 10 M, as well as many indicators such as Price To Sales Ratio of 34.33, Dividend Yield of 1.87 or PTB Ratio of 4.07. Delcath financial statements analysis is a perfect complement when working with Delcath Systems Valuation or Volatility modules.
Delcath | Operating Margin |
Latest Delcath Systems' Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Delcath Systems over the last few years. It is Delcath Systems' Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Delcath Systems' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (0.50) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Delcath Operating Margin Regression Statistics
| Arithmetic Mean | (42.76) | |
| Coefficient Of Variation | (138.19) | |
| Mean Deviation | 45.18 | |
| Median | (12.94) | |
| Standard Deviation | 59.09 | |
| Sample Variance | 3,491 | |
| Range | 149 | |
| R-Value | 0.71 | |
| Mean Square Error | 1,844 | |
| R-Squared | 0.51 | |
| Significance | 0 | |
| Slope | 9.43 | |
| Total Sum of Squares | 48,876 |
Delcath Operating Margin History
About Delcath Systems Financial Statements
Investors use fundamental indicators, such as Delcath Systems' Operating Margin, to determine how well the company is positioned to perform in the future. Although Delcath Systems' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York. Delcath Systems operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 55 people.
Currently Active Assets on Macroaxis
When determining whether Delcath Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Delcath Systems' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Delcath Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Delcath Systems Stock:Check out the analysis of Delcath Systems Correlation against competitors. For more detail on how to invest in Delcath Stock please use our How to Invest in Delcath Systems guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Delcath Systems. If investors know Delcath will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Delcath Systems listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.17) | Revenue Per Share 0.505 | Quarterly Revenue Growth 14.689 | Return On Assets (0.82) | Return On Equity (4.79) |
The market value of Delcath Systems is measured differently than its book value, which is the value of Delcath that is recorded on the company's balance sheet. Investors also form their own opinion of Delcath Systems' value that differs from its market value or its book value, called intrinsic value, which is Delcath Systems' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Delcath Systems' market value can be influenced by many factors that don't directly affect Delcath Systems' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Delcath Systems' value and its price as these two are different measures arrived at by different means. Investors typically determine if Delcath Systems is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Delcath Systems' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.